Concepedia
Statistics
Publications
4
Citations
150
H-Index
Active since
2020
Affiliations
The University of Texas MD Anderson Cancer Center(Current)
The University of Texas Health Science Center at Houston
Stanley Ly is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer stem cells.
Publications per year
2020–2022
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cells
Stanley Ly, Vivek Anand, Fouad El-Dana et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text
Medicine, Oncology, Pharmacology +17
Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway
Bin Yuan, Fouad El Dana, Stanley Ly et al. · PLoS ONE · 2020 · 36 citations · Full text
Medicine, Cell Biology, Oncology +17
Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer
Appalaraju Jaggupilli, Stanley Ly, Khoa Nguyen et al. · British Journal of Cancer · 2021 · 32 citations · Full text
Medicine, Cancer Biology, Oncology +12
Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML
Anudishi Tyagi, Stanley Ly, Fouad El-Dana et al. · Blood · 2022 · 31 citations · Full text
Life Sciences, Immunology, Oncology +17
1–4 of 4